30 Polen Capital Abbott Laboratories Trades
Polen Capital acquired 13.5 Million Abbott Laboratories shares worth $1.47 Billion. That's 3.37% of their equity portfolio (12th largest holding). The first Abbott Laboratories trade was made in Q3 2013. Since then Polen Capital bought shares sixteen more times and sold shares on thirteen occasions. The stake costed the investor $1.21 Billion, netting the investor a gain of 22% so far.
News about Abbott Laboratories and Polen Capital
Aristotle Capital Management LLC Sells 7,767 Shares of Abbott Laboratories (NYSE:ABT)
Aristotle Capital Management LLC decreased its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 12.1% in the second quarter, according to the comp...
Fort Pitt Capital Group LLC Boosts Stock Holdings in Abbott Laboratories (NYSE:ABT)
… 69.62%. Abbott Laboratories Company Profile (Free Report) Abbott Laboratories , together with … in four segments: Established Pharmaceutical Products, Diag...
Abbott Laboratories (NYSE:ABT) Stake Lifted by Osborne Partners Capital Management LLC
… 24th. Wolfe Research upgraded Abbott Laboratories from an “underperform” rating … on ABT Abbott Laboratories Company Profile (Free Report) Abbott Laborator...
Abbott Laboratories And More On CNBC''s ''Final Trades''
On CNBC’s " Halftime Report Final Trades ," Bryn Talkington of Requisite Capital Management named Innovator U.S. Equity Power Buffer ETF October (NYSE: POCT ...